To accelerate potential completion of ongoing partnership restructuring negotiations, Orchestra BioMed and Terumo have elected to enter a mediation process and are currently working on a procedural ...

Chardan Capital reissued their buy rating on shares of Clearside Biomedical (NASDAQ:CLSD – Free Report) in a research note published on Friday morning,Benzinga reports. Chardan Capital currently has a ...

STOCKHOLM–Scientific and analytical instruments provider Advanced Instruments agreed to buy Nova Biomedical in a deal that ...

Successful End-of-Phase 2 Meeting with FDA Results in Alignment on Phase 3 Plans for CLS-AX in Wet AMD - - Asia-Pacific Partner’s New Drug Application for ARCATUS® (XIPERE®) for Uveitic Macular Edema ...

One of the biggest hurdles in the sugar and ethanol industries is strict government regulations on wastewater management, ...